McCormick Announces Stock Split and Earnings Beat
McCormick reported better than expected second-quarter financial results and a 2-for-1 stock split before the markets opened on Tuesday.
All Work
Chris Lange
Genfit and Lab Corp Partner Up For NASH Liver Test
Genfit SA (NASDAQ: GNFT) shot up on Monday after the company announced an agreement with Lab Corporation of America Holdings (NYSE: LH | LH Price Prediction). This agreement is ultimately for Genfit’s technology to…
Eiger BioPharmaceuticals COVID-19 Study Fails to Live Up to Expectations
Eiger BioPharmaceuticals has announced disappointing results from a study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
Why This Tesla Deal Is Huge for Piedmont Lithium
Piedmont Lithium has announced a binding agreement with Tesla to supply spodumene concentrate from its North Carolina deposit. Shares of Piedmont nearly tripled on the news.
Should Aquestive Therapeutics Be Worried About This FDA Response?
Aquestive Therapeutics said that it had received a negative response from the FDA concerning its treatment for the management of seizure clusters.
Is the FDA’s Hold on Inovio’s COVID-19 Vaccine Study Too Much?
Things aren’t looking up for Inovio Pharmaceuticals, after the FDA notified the company that it was placing a partial hold on its COVID-19 vaccine study.
Conagra, Constellation Brands, Micron, Pepsi and More Major Earnings This Week
24/7 Wall St. has previewed PepsiCo, Micron Technology and some of the other key companies expected to report results this week.
Why This Analyst Sees Nearly 30% More Upside in DraftKings
As more states loosen gambling restrictions, Argus expects DraftKings to benefit from its market leadership.
Biotech Short Sellers Hike Their Bets
The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Short Sellers Get a Little Mixed Up on Semiconductors
The September 15 short interest data have been compared with the previous report, and short interest moves were mixed on most of these selected semiconductor stocks.
Why Amgen Is Called to Outperform Large-Cap Biotechs
Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20% upside to the stock's recent trading price.
10 Things You Should Know About SPI Energy
Why is SPI Energy stock running so much, and what makes it stand out? Here are 10 things to know about the company before investing.
Do Darden’s Earnings Signal a Broader Restaurant Recovery?
Darden Restaurants released mixed fiscal first-quarter financial results and said it resumed its dividend before the markets opened on Thursday.
Laird Super Food IPO Goes From Plant-Based Riches to Gold
Emerging consumer products provider Laird Super Food was another initial public offering making a big splash in the market on Wednesday.
GoodRx Enters the Market With a Bang
Telemedicine platform provider GoodRx entered the market with a bang on Wednesday.
Is It Over for AC Immune After This Alzheimer’s Study?
AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.
MediciNova Takes a Big Step in the Fight Against COVID-19
MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.
Meet the Newest Company to Break Into Electric Vehicles
SPI Energy shares more than tripled on Wednesday after the company announced that it would be getting into the electric vehicle business.
Why Stitch Fix May Need Stitches After Q4 Results
Stitch Fix posted a larger than expected net loss for its fiscal fourth-quarter, and shares plunged in early trading Wednesday.
How CleanSpark Survived Monday’s Market Carnage
CleanSpark, Inc. (NASDAQ: CLSK) closed Monday on a positive note although the markets slumped. The reason behind this move was that the firm announced the commissioning of its software on a new solar plus…